Censis Technologies

Censis has been owned by private equity firm GTCR since 2017, when GTCR acquired a majority stake. Prior to that, the company was owned by its founders and other investors. The exact ownership split is not publicly disclosed, but GTCR typically takes control positions in its portfolio companies.

Censis addresses the challenge of surgical instrument loss and inefficiency in hospital sterile processing departments. Its CensiTrac platform uses RFID and barcode technology to track each instrument through the cleaning, sterilization, assembly, and storage process. This reduces manual errors, prevents instruments from being misplaced or lost, and ensures that surgical sets are complete before procedures, which hospitals say lowers costs and improves patient outcomes.

No. Censis Technologies is a healthcare technology company owned by private equity firm GTCR. It is not structured as a family office. The firm's capital is deployed through its operations as a portfolio company, not as an allocator into external investments.

Censis reports that its platform is used in over 400 hospitals and surgery centers across North America. The company's client base includes large health systems such as HCA Healthcare and community hospitals. The number is per publicly available case studies and marketing materials.

Censis itself does not make investments; it is an operating company. However, its owner GTCR uses a 'Growth Buyout' strategy, acquiring majority stakes in growth-stage companies and partnering with management. For direct capital allocation, GTCR targets companies with $10–$100 million in EBITDA in healthcare IT and services.

Yes, Censis competes with companies like iRIS (owned by Getinge), TagWorks (owned by Steris), and XTrac (by Becton Dickinson). The instrument tracking market is relatively consolidated among a few vendors. Censis' differentiator is its focus solely on perioperative workflow, while competitors often bundle tracking with broader sterilization equipment.

Censis is headquartered in Franklin, Tennessee, near Nashville. Its software is deployed across over 400 hospitals in the United States and Canada. The company does not have disclosed international offices, though its platform is used in some Canadian healthcare facilities. There is no public information about expansion into other continents.